Počet záznamov: 1
alemtuzumab
SYS d000074323 LBL 00000nx^^^2200181-^^45^^ 005 20240119200807.7 100 $a 20180101asloy0103 ba0 152 $b mesh 250 $a alemtuzumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2018 (1995) $8 eng 330 1-
$a An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY. $8 eng 450 $a protilátka monoklonálna Campath-1H $5 e $8 slo 450 $a Lemtrada $5 e $8 slo 550 $3 sllk_un_auth*d000074301 $Y CD52 Antigen $5 F $a antigén CD52 686 $a D12.776.124.486.485.114.224.060.313 686 $a D12.776.124.790.651.114.224.060.375 686 $a D12.776.377.715.548.114.224.200.375 750 $a Alemtuzumab $8 eng 801 -0
$a SK $b BA006 $c 20180615 801 -2
$a SK $b BA006 $c 20180619 801 -2
$a SK $b BA006 $c 20180706 980 $x M
Počet záznamov: 1